Tumor microenvironment: Sanctuary of the devil.
1Institute of Genetics, School of Medicine, Zhejiang University, Hangzhou, China.
Cancer Letters
|August 16, 2015
Summary
Targeting the tumor microenvironment alongside traditional cancer treatments shows promise for improving outcomes. Understanding the complex interactions within this microenvironment is key to developing effective combination therapies for cancer eradication.
Area of Science:
- Oncology
- Cancer Biology
- Immunology
Background:
- Tumor cells dynamically interact with their surrounding microenvironment.
- The tumor microenvironment significantly influences cancer progression and treatment response.
- Emerging evidence highlights the therapeutic potential of targeting the tumor microenvironment.
Purpose of the Study:
- To review recent advancements in understanding the tumor microenvironment.
- To summarize key examples of tumor cell-microenvironment interactions.
- To underscore the importance of the microenvironment in cancer pathophysiology.
Main Methods:
- Literature review of current research on tumor microenvironment.
- Analysis of selected studies detailing tumor cell-microenvironment crosstalk.
- Synthesis of findings to illustrate pathophysiological mechanisms.
Main Results:
- Tumor microenvironment interactions are crucial for cancer development.
- Specific examples demonstrate how microenvironmental crosstalk affects malignancy.
- Enhanced understanding of these interactions provides new therapeutic avenues.
Conclusions:
- Targeting the tumor microenvironment offers a promising strategy to complement conventional cancer therapies.
- Further research into tumor microenvironment pathophysiology will guide rational design of combination treatments.
- This field holds significant potential for advancing cancer eradication strategies.
Related Concept Videos
The Tumor Microenvironment
8.2K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.2K
The Tumor Microenvironment
3.1K
3.1K
Tumor Immunotherapy
2.3K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.3K
Tumor Progression
7.9K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.9K
Tumor Progression
3.6K
3.6K
Metastasis
6.9K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.9K


